The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 07, 2007
Filed:
May. 12, 2004
Gregory M. Shutske, Pittstown, NJ (US);
James A. Hendrix, Hillsborough, NJ (US);
John G. Jurcak, Bethlehem, PA (US);
Brian S. Freed, Phillipsburg, NJ (US);
Nicholas J. Hrib, Hillsborough, NJ (US);
John D. Tomer, Iv, Greenfield, IN (US);
Reda G. Hanna, Allentown, PA (US);
Gregory M. Shutske, Pittstown, NJ (US);
James A. Hendrix, Hillsborough, NJ (US);
John G. Jurcak, Bethlehem, PA (US);
Brian S. Freed, Phillipsburg, NJ (US);
Nicholas J. Hrib, Hillsborough, NJ (US);
John D. Tomer, IV, Greenfield, IN (US);
Reda G. Hanna, Allentown, PA (US);
Aventis Pharmaceuticals Inc., Bridgewater, NJ (US);
Abstract
The compounds are of the class of benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives, useful as Dantagonists. Said compounds are useful for the treatment of medical conditions mediated by inhibition of Dreceptor. These conditions comprise, for example, Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, Substance Dependence, Parkinson's Disease, Parkinsonism, Tardive Diskinesia, Gilles de la Tourette Syndrome, Conduct Disorder, and Oppositional Defiant Disorder. A further aspect of the invention is to provide a pharmaceutical composition, intermediates, and a method of making said class of compounds.